TY - JOUR
T1 - Development and internal validation of clinical prediction models for scrub typhus and doxycycline-treatable causes in paediatric acute encephalitis syndrome in Karnataka, India
T2 - a multicentre, prospective study
AU - Damodar, Tina
AU - Jose, Maria
AU - Kinhal, Uddhava V.
AU - Singh, Bhagteshwar
AU - Telang, Surbhi
AU - Lekha, Akhila
AU - Marate, Srilatha
AU - Prabhu, Namratha
AU - Pattabiraman, Chitra
AU - Parthipulli Vasuki, Prathyusha
AU - Lalitha, A. V.
AU - Dsouza, Fulton Sebastian
AU - Sajjan, Sushma Veeranna
AU - Basavaraja, Gangasamudra Veerappa
AU - Kariyappa, Mallesh
AU - Michael, Benedict Daniel
AU - Mani, Reeta S.
AU - Solomon, Tom
AU - Gowda, Vykuntaraju K.
AU - Ravi, Vasanthapuram
AU - Yadav, Ravi
AU - Turtle, Lance
AU - Kolamunnage-Dona, Ruwanthi
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/8/1
Y1 - 2025/8/1
N2 - Background: Scrub typhus and other doxycycline-treatable infections are significant contributors of acute encephalitis syndrome (AES) in India. Limited surveillance in South India has hindered their recognition and the inclusion of doxycycline in treatment protocols. We aimed to systematically investigate infectious aetiologies of AES in children from Karnataka, India, and develop clinical prediction models for diagnosing scrub typhus and guiding clinical decisions for doxycycline therapy. Methods: This multicentre, prospective study enrolled children aged >28 days to 18 years with AES presenting to three tertiary care hospitals in Bengaluru, India. Primary outcomes were microbiological diagnosis of AES and clinical prediction models for diagnosing scrub typhus and identifying patients with doxycycline-treatable causes. Models were developed using multivariable logistic regression, internally validated, and simplified into point-scoring systems. Model performance was evaluated using c-statistics, calibration slopes, and calibration-in-the-large, adhering to TRIPOD guidelines. Findings: Between February 2020 and February 2023, 714 children were screened, of whom 587 were included. Of these, 315 (54%) had a microbiological diagnosis. Scrub typhus accounted for 138/315 (44%), and doxycycline-treatable causes were diagnosed in 193/315 (61%) of these cases. Key predictors associated with both scrub typhus and doxycycline-treatable causes were age, illness duration, lymphadenopathy, oedema, hepatomegaly, lymphocyte count, platelet count, and serum albumin levels. Adjusted c-statistics were 0.83 (95% CI: 0.78–0.87) for the scrub typhus model and 0.75 (95% CI: 0.7–0.81) for the doxycycline model, with calibration slopes of 0.85 (0.82–0.88) and 0.83 (0.78–0.87), respectively. CITL values were −0.03 (−0.06–0) and 0.05 (0.02–0.09). Points-based scores predicted probabilities ranging from 5% to 99.8% (scrub typhus model) and 20%–99% (doxycycline-treatable model). Interpretation: Scrub typhus was the most common microbiological diagnosis, and most patients had a doxycycline-treatable cause, underscoring the need to prioritise doxycycline in empirical treatment protocols in South India. The models demonstrated strong performance; however external validation is necessary for broader applicability. Funding: DBT/ Wellcome Trust India Alliance Fellowship IA/CPHE/18/1/503960.
AB - Background: Scrub typhus and other doxycycline-treatable infections are significant contributors of acute encephalitis syndrome (AES) in India. Limited surveillance in South India has hindered their recognition and the inclusion of doxycycline in treatment protocols. We aimed to systematically investigate infectious aetiologies of AES in children from Karnataka, India, and develop clinical prediction models for diagnosing scrub typhus and guiding clinical decisions for doxycycline therapy. Methods: This multicentre, prospective study enrolled children aged >28 days to 18 years with AES presenting to three tertiary care hospitals in Bengaluru, India. Primary outcomes were microbiological diagnosis of AES and clinical prediction models for diagnosing scrub typhus and identifying patients with doxycycline-treatable causes. Models were developed using multivariable logistic regression, internally validated, and simplified into point-scoring systems. Model performance was evaluated using c-statistics, calibration slopes, and calibration-in-the-large, adhering to TRIPOD guidelines. Findings: Between February 2020 and February 2023, 714 children were screened, of whom 587 were included. Of these, 315 (54%) had a microbiological diagnosis. Scrub typhus accounted for 138/315 (44%), and doxycycline-treatable causes were diagnosed in 193/315 (61%) of these cases. Key predictors associated with both scrub typhus and doxycycline-treatable causes were age, illness duration, lymphadenopathy, oedema, hepatomegaly, lymphocyte count, platelet count, and serum albumin levels. Adjusted c-statistics were 0.83 (95% CI: 0.78–0.87) for the scrub typhus model and 0.75 (95% CI: 0.7–0.81) for the doxycycline model, with calibration slopes of 0.85 (0.82–0.88) and 0.83 (0.78–0.87), respectively. CITL values were −0.03 (−0.06–0) and 0.05 (0.02–0.09). Points-based scores predicted probabilities ranging from 5% to 99.8% (scrub typhus model) and 20%–99% (doxycycline-treatable model). Interpretation: Scrub typhus was the most common microbiological diagnosis, and most patients had a doxycycline-treatable cause, underscoring the need to prioritise doxycycline in empirical treatment protocols in South India. The models demonstrated strong performance; however external validation is necessary for broader applicability. Funding: DBT/ Wellcome Trust India Alliance Fellowship IA/CPHE/18/1/503960.
KW - Acute encephalitis syndrome (AES)
KW - Clinical prediction models
KW - Doxycycline-treatable infections
KW - Paediatric encephalitis
KW - Point-scoring systems
KW - Scrub typhus
U2 - 10.1016/j.lansea.2025.100626
DO - 10.1016/j.lansea.2025.100626
M3 - Article
AN - SCOPUS:105008978434
SN - 2772-3682
VL - 39
JO - The Lancet Regional Health - Southeast Asia
JF - The Lancet Regional Health - Southeast Asia
M1 - 100626
ER -